Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.
Anti-TSH receptor antibody
Graves’ disease
Pretibial myxedema
SARS-CoV-2 vaccine
Thyroid eye disease
mRNA COVID-19 vaccine
Journal
Annales d'endocrinologie
ISSN: 2213-3941
Titre abrégé: Ann Endocrinol (Paris)
Pays: France
ID NLM: 0116744
Informations de publication
Date de publication:
20 Oct 2023
20 Oct 2023
Historique:
received:
28
09
2023
revised:
09
10
2023
accepted:
09
10
2023
pubmed:
23
10
2023
medline:
23
10
2023
entrez:
22
10
2023
Statut:
aheadofprint
Résumé
A 70-year-old female had a history of thyroid surgery for benign nodules and Graves' disease. Following mRNA COVID-19 vaccination, she presented Graves' orbitopathy and pretibial myxedema. Symptoms of thyroid eye disease and thyroid dermopathy improved after 500-mg methylprednisolone infusions.
Identifiants
pubmed: 37866430
pii: S0003-4266(23)00713-8
doi: 10.1016/j.ando.2023.10.004
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Elsevier Masson SAS. All rights reserved.